These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
414 related items for PubMed ID: 32773805
1. [Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection]. Zhao SM, Yang TJ, Xu CM, Guo XF, Ma YK, Chen XJ, Li X, He CH. Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug 18; 52(4):701-704. PubMed ID: 32773805 [Abstract] [Full Text] [Related]
2. Bladder cancer local staging: multiparametric MRI performance following transurethral resection. van der Pol CB, Shinagare AB, Tirumani SH, Preston MA, Vangel MG, Silverman SG. Abdom Radiol (NY); 2018 Sep 18; 43(9):2412-2423. PubMed ID: 29313114 [Abstract] [Full Text] [Related]
3. Evaluation of magnetic resonance imaging for bladder cancer detection following transurethral resection of bladder tumour (TURBT). Khwaja SA, Caglic I, Shaida N, Colquhoun AJ, Turner W, Barrett T. Abdom Radiol (NY); 2024 Jul 18; 49(7):2340-2348. PubMed ID: 38717615 [Abstract] [Full Text] [Related]
4. Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT. James N, Pirrie S, Liu W, Catto J, Jefferson K, Patel P, Hughes A, Pope A, Nanton V, Mintz HP, Knight A, Gallagher J, Bryan RT. Health Technol Assess; 2024 Aug 18; 28(42):1-65. PubMed ID: 39246267 [Abstract] [Full Text] [Related]
6. Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion. Lee M, Shin SJ, Oh YT, Jung DC, Cho NH, Choi YD, Park SY. Eur Radiol; 2017 Sep 18; 27(9):3752-3758. PubMed ID: 28168374 [Abstract] [Full Text] [Related]
8. Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer. Xu S, Yao Q, Liu G, Jin D, Chen H, Xu J, Li Z, Wu G. Eur Radiol; 2020 Mar 18; 30(3):1804-1812. PubMed ID: 31773297 [Abstract] [Full Text] [Related]
9. [Diagnostic value of 3.0-tesla high-resolution magnetic resonance imaging for invasion depth of rectal cancer]. Yao X, Song X, Wang Y. Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun 18; 19(6):668-74. PubMed ID: 27353102 [Abstract] [Full Text] [Related]
10. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease? Del Giudice F, Leonardo C, Simone G, Pecoraro M, De Berardinis E, Cipollari S, Flammia S, Bicchetti M, Busetto GM, Chung BI, Gallucci M, Catalano C, Panebianco V. BJU Int; 2020 Nov 18; 126(5):610-619. PubMed ID: 32783347 [Abstract] [Full Text] [Related]
17. T staging of rectal cancer: accuracy of diffusion-weighted imaging compared with T2-weighted imaging on 3.0 tesla MRI. Feng Q, Yan YQ, Zhu J, Xu JR. J Dig Dis; 2014 Apr 18; 15(4):188-94. PubMed ID: 24373561 [Abstract] [Full Text] [Related]
18. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy. Lista F, Andrés G, Cáceres F, Ramón de Fata F, Rodríguez-Barbero JM, Angulo JC. Actas Urol Esp; 2013 Apr 18; 37(7):419-24. PubMed ID: 23773823 [Abstract] [Full Text] [Related]